We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · August 26, 2020

STAT6 Variants Are Associated With Relapse of EoE in Patients Receiving Long-Term PPI Therapy

Clinical Gastroenterology and Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Gastroenterology and Hepatology
STAT6 Variants Associate With Relapse of Eosinophilic Esophagitis in Patients Receiving Long-Term Proton Pump Inhibitor Therapy
Clin. Gastroenterol. Hepatol. 2020 Aug 13;[EPub Ahead of Print], EB Mougey, V Nguyen, C Gutiérrez-Junquera, S Fernández-Fernández, ML Cilleruelo, A Rayo, B Borrell, E Román, C González-Lois, M Chao, H Al-Atrash, JP Franciosi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading